OBE THERAPY BIOTECHNOLOGY
2Patents
1Active
2Granted
28Portfolio score
Filing activity: Jun 29, 2000 → Dec 16, 2013
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6942967B1 | Target for treating athersclerosis, obesity and type II diabetes | Human Necessities | 2 | Expired |
| US9481709B2 | Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.